Forskning og utdanning
The European Commission, DG JRC - Joint Research Centre, based in Italy, needs services for evidence reviews for the European Commission Initiatives on cancer screening and care, with a maximum total value of 5,500,000 EUR over 4 years. The procurement is divided into two lots: Lot 1 focuses on mapping exercises and evidence reviews, including systematic reviews and the definition of Evidence to Decision frameworks for guideline development and updates, primarily for breast, colorectal, cervical, and lung cancer. Lot 2 involves similar mapping exercises and evidence reviews, including systematic reviews and the definition of quality indicators worksheets and requirements for the development and update of quality indicators, also with an emphasis on breast, colorectal, cervical, and lung cancer. The services are to provide continuity for the collection, analysis, and assessment of underpinning evidence for EC initiatives, following a uniform methodological framework. Offers will be evaluated based on quality (60%) and price (40%). PPMI Group, UAB, has a similar contract today.
Slipp å lese og skrive alt selv, la Cobrief gjøre det for deg!
Prøv Cobrief ProOm anbudet
- Kontakt telefon
- +32 2 299 11 11
- Kontakt e-post
- jrc-ispra-dir-f-procurement@ec.europa.eu
- Adresse
- Via Enrico Fermi 2749, I-21027 Ispra (VA)
The Disease Prevention Unit of the European Commission’s (EC) Joint Research Centre has been assigned with tasks in the field of cancer prevention and rare diseases that include the development of new European guidelines and quality assurance schemes for the six most prevalent cancer sites (breast, cervical, colorectal, gastric, lung and prostate cancer) representing over 50% of the cancer burden in the European Union. The purpose of this procurement procedure is to provide continuity for the collection, analysis and assessment of the underpinning evidence informing the EC initiatives, following a uniform methodological framework. The purpose of Lot 1 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing guidelines) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of Evidence to Decision frameworks (EtDs) for the development and update of guideline recommendations, with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer. The purpose of Lot 2 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing quality indicators) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of quality indicators worksheets and requirements for the development and update of quality indicators and requirements with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer.
Kvalifikasjonskrav
Tildelingskriterier
Beskrivelse
Please consult the procurement documents.
Beskrivelse
Please consult the procurement documents.
Se hele utlysningen
- Tittel
- Evidence reviews for the European Commission Initiatives on cancer screening and care
- Hovedkode
- Tilleggskoder
- Estimert verdi
- 5 500 000,00 €
- Varighet
- 48 måneder